Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands
Authors:
- 1 December 1997
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 35 (12) , 3026-31
Abstract
In order to determine the prevalence of vancomycin-resistant enterococci (VRE) in The Netherlands, 624 hospitalized patients from intensive care units or hemato-oncology wards in nine hospitals and 200 patients living in the community were screened for VRE colonization. Enterococci were found in 49% of the hospitalized patients and in 80% of the patients living in the community. Of these strains, 43 and 32%, respectively, were Enterococcus faecium. VRE were isolated from 12 of 624 (2%) and 4 of 200 (2%) hospitalized patients and patients living in the community, respectively. PCR analysis of these 16 strains and 11 additional clinical VRE isolates from one of the participating hospitals revealed 24 vanA gene-containing, 1 vanB gene-containing, and 2 vanC1 gene-containing strains. All strains were cross-resistant to avoparcin but were sensitive to the novel glycopeptide antibiotic LY333328. Genotyping of the strains by arbitrarily primed PCR and pulsed-field gel electrophoresis revealed a high degree of genetic heterogeneity. This underscores a lack of hospital-driven endemicity of VRE clones. It is suggested that the VRE in hospitalized patients have originated from unknown sources in the community.Keywords
This publication has 18 references indexed in Scilit:
- Overgrowth of Enterococcus faecium in the Feces of Patients with Hematologic MalignanciesClinical Infectious Diseases, 1996
- Nosocomial Infections with Vancomycin-Resistant Enterococcus fuecium in Liver Transplant Recipients: Risk Factors for Acquisition and MortalityClinical Infectious Diseases, 1996
- Influence of Oral Glycopeptides on the Fecal Flora of Human Volunteers: Selection of Highly Glycopeptide-Resistant EnterococciThe Journal of Infectious Diseases, 1996
- Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans?Journal of Antimicrobial Chemotherapy, 1996
- Characterization of antimicrobial resistance in enterococci of animal originAntimicrobial Agents and Chemotherapy, 1995
- Editorial Response: What Can We Do About Vancomycin-Resistant Enterococci?Clinical Infectious Diseases, 1995
- vanA-mediated high-level glycopeptide resistance inEnterococcus faeciumfrom animal husbandryFEMS Microbiology Letters, 1995
- Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faeciumJournal of Antimicrobial Chemotherapy, 1994
- Microbiological assay of avoparcin in animal feeds and pre-mixes—co-operative studyThe Analyst, 1992
- Carriage of group D streptococci in the human bowel.Journal of Clinical Pathology, 1978